Stay updated on Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial
Sign up to get notified when there's something new on the Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial page.

Latest updates to the Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision entry v3.6.6 is added to the record history and the previous v3.6.5 entry is removed, updating the list of revisions on the page.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedA new revision entry v3.6.5 was added to the history, replacing v3.6.4, signaling a back-end or interface update to the page.SummaryDifference0.1%

- Check50 days agoChange DetectedA new revision entry, Revision: v3.6.4, was added to the history and the previous Revision: v3.6.3 entry was removed, updating the study record's release notes.SummaryDifference0.1%

- Check72 days agoChange DetectedAdds a new revision entry labeled v3.6.3 to the study history, representing an updated version in the history log. It indicates an internal update to the record without altering study data or outcomes.SummaryDifference0.1%

- Check79 days agoChange DetectedA new Study Status entry was added on 2026-06-22 as part of the latest version (Revision: v3.6.2), and the older revision (v3.6.0) from 2026-03-27 was removed. This update reflects refreshed versioning and status-tracking in the study's history.SummaryDifference0.5%

- Check93 days agoChange DetectedNew UI elements 'Check who can join' and 'Find Contact Information' appear, and the revision tag updated to v3.6.0 (replacing v3.5.5). These changes reflect UI and release updates rather than modifications to study data.SummaryDifference0.5%

Stay in the know with updates to Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial page.